ClinicalTrials.govpublic full text
Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)
shiga-like toxin-producing escherichia coli, stec-hus, shiga-like toxin-producing escherichia coli hemolytic-uremic syndrome, uncontrolled complement activation, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856097
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.